US Bancorp DE Has $14.84 Million Position in Smith & Nephew plc (SNN)

US Bancorp DE lowered its holdings in Smith & Nephew plc (NYSE:SNN) by 19.5% in the third quarter, HoldingsChannel reports. The firm owned 400,157 shares of the medical equipment provider’s stock after selling 96,921 shares during the quarter. US Bancorp DE’s holdings in Smith & Nephew were worth $14,841,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Checchi Capital Advisers LLC acquired a new stake in Smith & Nephew in the second quarter valued at $204,000. Capital Fund Management S.A. acquired a new stake in Smith & Nephew in the second quarter valued at $210,000. Avestar Capital LLC lifted its stake in Smith & Nephew by 25.8% in the third quarter. Avestar Capital LLC now owns 7,910 shares of the medical equipment provider’s stock valued at $276,000 after acquiring an additional 1,623 shares during the last quarter. Alps Advisors Inc. acquired a new stake in Smith & Nephew in the second quarter valued at $302,000. Finally, SG Americas Securities LLC acquired a new stake in Smith & Nephew in the second quarter valued at $372,000. Hedge funds and other institutional investors own 8.53% of the company’s stock.

NYSE SNN opened at $37.56 on Thursday. The company has a quick ratio of 1.05, a current ratio of 2.13 and a debt-to-equity ratio of 0.31. The stock has a market cap of $16.17 billion, a PE ratio of 19.77, a P/E/G ratio of 3.02 and a beta of 0.58. Smith & Nephew plc has a 52-week low of $32.22 and a 52-week high of $39.85.

A number of brokerages have commented on SNN. UBS Group cut shares of Smith & Nephew from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 8th. Zacks Investment Research upgraded shares of Smith & Nephew from a “sell” rating to a “hold” rating in a research note on Tuesday, August 7th. Canaccord Genuity restated a “buy” rating and set a $42.00 target price on shares of Smith & Nephew in a research note on Monday, August 6th. Finally, HSBC cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $41.00.

COPYRIGHT VIOLATION WARNING: “US Bancorp DE Has $14.84 Million Position in Smith & Nephew plc (SNN)” was originally published by WKRB News and is the sole property of of WKRB News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.wkrb13.com/2018/11/08/us-bancorp-de-has-14-84-million-position-in-smith-nephew-plc-snn.html.

Smith & Nephew Profile

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Further Reading: S&P 500 Index

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply